title: Human electrophysiological correlates of learned irrelevance: effects of the muscarinic M1 antagonist biperiden.
abstract: Learned irrelevance (LIrr) refers to a reduction in associative learning after pre-exposure of the conditioned and unconditioned stimulus in a non-contingent fashion. This paradigm might serve as a translational model for (pre)attentive information processing deficits in schizophrenia. This is the first study to investigate the event-related potentials (ERPs) of a within-subject LIrr paradigm in humans. Furthermore, the effects of the muscarinic M1 antagonist biperiden on LIrr were assessed. As expected, LIrr was found to be intact in young healthy volunteers after placebo. Furthermore, in the placebo condition P3b latency was decreased for target stimuli, which were pre-cued. This suggests that the predictability of the occurrence of these stimuli is mainly reflected by this ERP component. Biperiden had no effect on the behavioural LIrr measures, although prolonged reaction times were evident. Biperiden increased the N1 amplitude of the pre-exposed predictor letters, suggesting an effect of this drug on early perceptual processing. In conclusion, the within-subject paradigm used in the current study in combination with electroencephalography can reveal brain mechanisms involved in LIrr. M1 antagonism did not affect LIrr performance but seemed to influence early information processing.
authors.affiliation: Faculty of Psychology and Neuroscience, Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands. inge.klinkenberg@maastrichtuniversity.nl
authors.forename: Inge
authors.initials: I
authors.lastname: Klinkenberg
authors.forename: Arjan
authors.initials: A
authors.lastname: Blokland
authors.forename: Wim
authors.initials: W
authors.lastname: Riedel
authors.forename: Anke
authors.initials: A
authors.lastname: Sambeth
mesh_terms: D000328:Adult; D001712:Biperiden / Q000494:pharmacology / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004569:Electroencephalography / Q000379:methods; D055724:Electrophysiological Phenomena / Q000187:drug effects / Q000502:physiology; D005071:Evoked Potentials / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006801:Humans; D007858:Learning / Q000187:drug effects* / Q000502:physiology; D008297:Male; D018727:Muscarinic Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D010775:Photic Stimulation / Q000379:methods; D011930:Reaction Time / Q000187:drug effects* / Q000502:physiology; D043643:Receptor, Muscarinic M1 / Q000037:antagonists & inhibitors* / Q000502:physiology; D055815:Young Adult
chemical_list: D018727:Muscarinic Antagonists; D043643:Receptor, Muscarinic M1; D001712:Biperiden
references.citation: Science. 1964 Jul 10;145(3628):180-2
references.pmid: 14171563
references.citation: Behav Brain Res. 2005 Apr 30;159(2):267-75
references.pmid: 15817189
references.citation: Behav Brain Res. 2009 Dec 7;204(2):335-51
references.pmid: 19376161
references.citation: Psychon Bull Rev. 2005 Apr;12(2):224-43
references.pmid: 16082802
references.citation: Psychophysiology. 1981 Sep;18(5):493-513
references.pmid: 7280146
references.citation: J Clin Psychopharmacol. 2000 Feb;20(1):77-83
references.pmid: 10653212
references.citation: Science. 1965 Nov 26;150(3700):1187-8
references.pmid: 5852977
references.citation: Mol Psychiatry. 1996 Mar;1(1):54-8
references.pmid: 9118315
references.citation: Psychopharmacology (Berl). 2005 Sep;181(3):582-94
references.pmid: 16041534
references.citation: Science. 1967 Mar 17;155(3768):1436-9
references.pmid: 6018511
references.citation: Schizophr Res. 1996 Jul 5;20(3):315-26
references.pmid: 8827859
references.citation: Schizophr Bull. 2011 Sep;37(5):973-81
references.pmid: 20080901
references.citation: Psychophysiology. 1997 Nov;34(6):703-11
references.pmid: 9401424
references.citation: Integr Physiol Behav Sci. 2002 Jul-Sep;37(3):188-214
references.pmid: 12435211
references.citation: Clin Neurophysiol. 2000 Jan;111(1):29-39
references.pmid: 10656508
references.citation: Clin Neurophysiol. 2004 Nov;115(11):2602-15
references.pmid: 15465450
references.citation: Am J Psychiatry. 2001 Jun;158(6):918-25
references.pmid: 11384900
references.citation: Res Commun Chem Pathol Pharmacol. 1990 Sep;69(3):261-70
references.pmid: 2236897
references.citation: Schizophr Res. 1991 Jan-Feb;4(1):23-30
references.pmid: 2009253
references.citation: Neuropsychopharmacology. 2011 Nov;36(12):2477-87
references.pmid: 21814184
references.citation: Mol Psychiatry. 2000 Mar;5(2):203-7
references.pmid: 10822350
references.citation: Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97
references.pmid: 12601500
references.citation: Arch Intern Med. 1989 Nov;149(11):2414-20
references.pmid: 2684071
references.citation: Neurosci Biobehav Rev. 2005;29(6):1001-20
references.pmid: 15979142
references.citation: Schizophr Res. 2000 Sep 29;45(1-2):103-14
references.pmid: 10978878
references.citation: Drug Metab Dispos. 1990 Mar-Apr;18(2):258-63
references.pmid: 1971583
references.citation: Int J Psychophysiol. 2006 May;60(2):172-85
references.pmid: 16510201
references.citation: Psychophysiology. 1986 Nov;23(6):695-703
references.pmid: 3823345
references.citation: Psychophysiology. 1997 Mar;34(2):131-56
references.pmid: 9090263
references.citation: Int J Neurosci. 1986 Aug;30(1-2):11-5
references.pmid: 3744706
references.citation: Acta Psychiatr Scand Suppl. 1981;291:20-8
references.pmid: 6113732
references.citation: J R Soc Med. 2000 Sep;93(9):457-62
references.pmid: 11089480
references.citation: Biol Psychiatry. 2000 Sep 1;48(5):381-8
references.pmid: 10978721
references.citation: Pharmacopsychiatry. 1987 Mar;20(2):72-7
references.pmid: 3588663
references.citation: Am J Psychiatry. 1992 Oct;149(10):1393-4
references.pmid: 1530077
references.citation: Clin Neurophysiol. 2002 Oct;113(10):1544-57
references.pmid: 12350430
references.citation: Mol Psychiatry. 2009 Nov;14(11):1017-23
references.pmid: 18317461
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):225-33
references.pmid: 16901598
references.citation: Behav Brain Res. 2008 Nov 3;193(1):101-7
references.pmid: 18555542
references.citation: Prog Brain Res. 1980;54:717-22
references.pmid: 7220990
references.citation: Electroencephalogr Clin Neurophysiol Suppl. 1999;52:3-6
references.pmid: 10590970
references.citation: Cereb Cortex. 2007 Sep;17 Suppl 1:i51-60
references.pmid: 17726004
references.citation: Neuropsychopharmacology. 2004 Mar;29(3):619-25
references.pmid: 14694353
references.citation: Biol Psychiatry. 2007 May 15;61(10):1161-70
references.pmid: 17239354
references.citation: J Affect Disord. 1987 Mar-Apr;12(2):153-7
references.pmid: 2955007
references.citation: Life Sci. 1983 Nov 28;33(22):2187-96
references.pmid: 6139728
references.citation: Behav Brain Res. 2005 Jan 30;156(2):277-88
references.pmid: 15582114
references.citation: Biol Psychiatry. 1992 Feb 15;31(4):365-77
references.pmid: 1558899
references.citation: Behav Brain Res. 2007 Jun 4;180(1):1-3
references.pmid: 17408763
references.citation: Neuropharmacology. 2012 Mar;62(3):1544-53
references.pmid: 21156184
references.citation: Biol Psychol. 1996 Mar 8;43(1):41-55
references.pmid: 8739613
references.citation: Psychophysiology. 1977 Sep;14(5):456-67
references.pmid: 905483
references.citation: J Pharmacol Exp Ther. 1992 Feb;260(2):576-80
references.pmid: 1346637
references.citation: Neuroimage. 2005 Aug 15;27(2):387-92
references.pmid: 15921933
references.citation: Neuroscience. 1995 May;66(2):321-35
references.pmid: 7477875
references.citation: Neuropsychologia. 1992 Aug;30(8):723-41
references.pmid: 1407488
references.citation: Psychophysiology. 2004 Jul;41(4):575-83
references.pmid: 15189480
references.citation: Electroencephalogr Clin Neurophysiol. 1988 Jun;69(6):523-31
references.pmid: 2453329
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):78-83
references.pmid: 20828595
references.citation: J Exp Psychol Hum Percept Perform. 1991 Nov;17(4):1057-74
references.pmid: 1837297
references.citation: Eur J Clin Pharmacol. 1984;27(5):619-21
references.pmid: 6519170
references.citation: J Neurosci Res. 2005 Sep 15;81(6):883-90
references.pmid: 16041805
references.citation: Hippocampus. 1993 Oct;3(4):491-516
references.pmid: 8269040
references.citation: Science. 1977 Aug 19;197(4305):792-5
references.pmid: 887923
references.citation: J Cogn Neurosci. 2009 Sep;21(9):1680-92
references.pmid: 18702574